Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum

BACKGROUND: Ovarian cancer is the most lethal gynecologic malignancy, with the majority of cases diagnosed at an advanced stage when treatments are less successful. Novel serum protein markers are needed to detect ovarian cancer in its earliest stage; when detected early, survival rates are over 90%...

Descripción completa

Detalles Bibliográficos
Autores principales: Boylan, Kristin LM, Andersen, John D, Anderson, Lorraine B, Higgins, LeeAnn, Skubitz, Amy PN
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893134/
https://www.ncbi.nlm.nih.gov/pubmed/20546617
http://dx.doi.org/10.1186/1477-5956-8-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893134/
https://www.ncbi.nlm.nih.gov/pubmed/20546617
http://dx.doi.org/10.1186/1477-5956-8-31

Ejemplares similares